Franklin FTSE Emerging Markets UCITS ETF (Acc) USD-Hedged

PhysicalIndex replication
AccumulatingDistribution policy
0.11 %TER
£7.76M Fund size
1,604Number of positions
0.52 % TD
29.47 %Top 10 share
USDCurrency
4SRI

Current price

£22.96
19 Nov 2026
1D
1W
1M
3M
6M
1Y
3Y
Max

Description

Objectives and Investment Policy Franklin FTSE Emerging Markets UCITS ETF (the “Fund”) aims to provide exposure to large and mid-capitalisation stocks in emerging market countries globally. The Fund seeks to track the performance of the FTSE Emerging Index NR (the “Index”) as closely as possible, regardless of whether the Index level rises or falls, while seeking to minimise as far as possible the tracking error between the Fund's performance and that of the Index. The Index is a broad free float market-capitalisation weighted index which captures large and mid-sized companies from emerging markets globally. The Index is derived from the FTSE Global Equity Index Series, an index which covers 98% of the world's investable market capitalisation. The Index is rebalanced quarterly in March, June, September and December. The securities in which the Fund invests will be primarily listed or traded on recognised markets globally in accordance with the limits set out in the UCITS Regulations. The Fund may use derivatives for efficient portfolio management purposes only. The investment manager will aim to replicate the Index by holding all of the Index securities in a similar proportion to their weighting in the Index. However, in certain circumstances full replication of the Index may not be reasonably practical or possible and in such circumstances the Fund may hold only those of the Index securities which are available or may invest in instruments that are not included in the Index but which the investment manager believes will help the Fund replicate the Index, e.g. securities which provide similar price and yield performance and risk profiles to constituents of the Index. Although the Index is generally well diversified, because of the market it reflects it contains constituents issued by the same body that may represent more than 10% of the Index. Accordingly, the Fund is permitted to hold positions in individual constituents of the Index issued by the same body of up to 20% of the Fund's Net Asset Value. The Fund may appeal to investors looking to track the performance of large and mid-capitalisation stocks in emerging market countries globally and who are willing to hold their investment over the medium to long term, for a minimum period of 3 to 5 years. The Fund may be suitable for investors who do not have specific knowledge and/or experience of financial markets and who understand that they may not get back the full amount invested in the Fund. The Fund's shares are listed and traded on one or more stock exchanges. In normal circumstances, only authorised participants (e.g. select financial institutions) may deal in shares directly with the Fund. Other investors can deal in shares daily through a broker on stock exchange(s) on which the shares are traded. For further information on the Objectives and Investment Policy of the Fund, please refer to the “Investment Objective and Strategy” section of the current prospectus of Franklin Templeton ICAV and the Fund supplement. Terms to Understand Mid-capitalisation stock: stock of companies with market capitalisation generally accounting accumulatively for the next 20% of the capitalisation of a domestic stock market below large-capitalisation stock. Derivatives: Financial instruments whose characteristics and value depend on the performance of one or more underlying assets, typically securities, indexes, currencies or interest rates. Emerging markets: Countries whose economy, stock market, political situation and regulatory framework are not fully developed. Large-capitalisation stock: stock of companies with large market capitalisation generally accounting accumulatively for the top 70% of the capitalisation of a domestic stock market. For accumulation shares, income from investments is reinvested in the Fund and reflected in the price of shares.

Return

Here you can see the performance (incl. distributions) of the Franklin FTSE Emerging Markets UCITS ETF (Acc) USD-Hedged.

Period Perfor­mance
1 Week-4.90 %
1 Month-7.15 %
3 Months-7.03 %
6 Months-5.28 %
1 Year+1.11 %
3 Years—
5 Years—
10 Years—
Since inception +17.87 %(8.25 % p.a.)
Year Perfor­mance
YTD+1.91 %
2025+10.65 %
2024+2.13 %
2023—
2022—
2021—
As of: 19 Nov 2026. Performance displayed in GBP

Master data

Key master data for the Franklin FTSE Emerging Markets UCITS ETF (Acc) USD-Hedged

Total expense ratio (TER) 0.11 %
Index replication Physical
Replication method Full
Distribution policy Accumulating
Fund size £7.76M
Fund launch 22 Oct 2024
Fund currency USD
Currency hedging No 
Fund domicileIrland
Risk indicator (SRI)
4 · medium risk class

Risk metrics

Key risk and analysis metrics for the Franklin FTSE Emerging Markets UCITS ETF (Acc) USD-Hedged

Volatility
14.62 % 1 Year
— 3 Years
— 5 Years
max. Drawdown
-10.18 % 1 Year
— 3 Years
— 5 Years
Sharpe Ratio
0.11 1 Year
— 3 Years
— 5 Years
XLM
112.65

Information about the FTSE Emerging NR USD Index

Index name FTSE Emerging NR USD (1)
Included securities 1,631
Stock positions 1,604
Bond positions 0
Cash and other positions 27

More ETFs tracking the FTSE Emerging NR USD Index

Here you can find alternative index funds for the FTSE Emerging NR USD.

Fund nameWKNTER
No results

Frequently asked questions

Here you will find all answers to your questions about the Franklin FTSE Emerging Markets UCITS ETF (Acc) USD-Hedged

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.